Article info

Download PDFPDF

Observational study on off-label use of tocilizumab in patients with severe COVID-19
Free

Authors

  1. Correspondence to Dr Laetitia Albertini, Pharmacist, Montfermeil, France; albertini.laetitia{at}gmail.com
View Full Text

Citation

Albertini L, Soletchnik M, Razurel A, et al
Observational study on off-label use of tocilizumab in patients with severe COVID-19

Publication history

  • Received June 15, 2020
  • Revised August 17, 2020
  • Accepted August 18, 2020
  • First published September 10, 2020.
Online issue publication 
December 18, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.